The FDA has approved three GLP-1s in particular for both type 2 diabetes treatment and weight loss: Liraglutide (Saxenda, Victoza): While effective, this once-daily injection generally leads to more modest weight loss compared to newer options (its been around since 2014)
This means potentially reducing the risk of age-related disease like cognitive decline and cardiovascular disease while enhancing healthy longevity
Side effects usually involve gastrointestinal (GI) tract or digestive symptoms
Long-term evidence is still limited, which is another reason to keep expectations realistic and check in with a professional
HSA and FSA funds may typically be used for both options
By following these tips and guidelines, you can build confidence and ensure that your GLP-1 weight loss medication regimen is safe, effective, and stress-free